174 related articles for article (PubMed ID: 22893629)
1. Exploratory clinical trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for imaging xC- transporter using positron emission tomography in patients with non-small cell lung or breast cancer.
Baek S; Choi CM; Ahn SH; Lee JW; Gong G; Ryu JS; Oh SJ; Bacher-Stier C; Fels L; Koglin N; Hultsch C; Schatz CA; Dinkelborg LM; Mittra ES; Gambhir SS; Moon DH
Clin Cancer Res; 2012 Oct; 18(19):5427-37. PubMed ID: 22893629
[TBL] [Abstract][Full Text] [Related]
2. (4S)-4-(3-18F-fluoropropyl)-L-glutamate for imaging of xC transporter activity in hepatocellular carcinoma using PET: preclinical and exploratory clinical studies.
Baek S; Mueller A; Lim YS; Lee HC; Lee YJ; Gong G; Kim JS; Ryu JS; Oh SJ; Lee SJ; Bacher-Stier C; Fels L; Koglin N; Schatz CA; Dinkelborg LM; Moon DH
J Nucl Med; 2013 Jan; 54(1):117-23. PubMed ID: 23232273
[TBL] [Abstract][Full Text] [Related]
3. Exploratory Clinical Investigation of (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate PET of Inflammatory and Infectious Lesions.
Chae SY; Choi CM; Shim TS; Park Y; Park CS; Lee HS; Lee SJ; Oh SJ; Kim SY; Baek S; Koglin N; Stephens AW; Dinkelborg LM; Moon DH
J Nucl Med; 2016 Jan; 57(1):67-9. PubMed ID: 26471694
[TBL] [Abstract][Full Text] [Related]
4. Prospective comparison of (4S)-4-(3-
Cheng MF; Huang YY; Ho BY; Kuo TC; Hsin LW; Shiue CY; Kuo HC; Jeng YM; Yen RF; Tien YW
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):810-820. PubMed ID: 30635754
[TBL] [Abstract][Full Text] [Related]
5. PET Imaging of L-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (x
Krys D; Mattingly S; Glubrecht D; Wuest M; Wuest F
Mol Imaging Biol; 2020 Dec; 22(6):1562-1571. PubMed ID: 32789819
[TBL] [Abstract][Full Text] [Related]
6. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study.
Kaira K; Oriuchi N; Otani Y; Shimizu K; Tanaka S; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Dobashi K; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
Clin Cancer Res; 2007 Nov; 13(21):6369-78. PubMed ID: 17975149
[TBL] [Abstract][Full Text] [Related]
7. Comparative Evaluation of [
Colovic M; Yang H; Southcott L; Merkens H; Colpo N; Bénard F; Schaffer P
J Nucl Med; 2023 Aug; 64(8):1314-1321. PubMed ID: 37116917
[TBL] [Abstract][Full Text] [Related]
8. [
Hoehne A; James ML; Alam IS; Ronald JA; Schneider B; D'Souza A; Witney TH; Andrews LE; Cropper HC; Behera D; Gowrishankar G; Ding Z; Wyss-Coray T; Chin FT; Biswal S; Gambhir SS
J Neuroinflammation; 2018 Feb; 15(1):55. PubMed ID: 29471880
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.
Sauter AW; Winterstein S; Spira D; Hetzel J; Schulze M; Mueller M; Pfannenberg C; Claussen CD; Klotz E; Hann von Weyhern C; Horger MS
J Nucl Med; 2012 Apr; 53(4):521-9. PubMed ID: 22414637
[TBL] [Abstract][Full Text] [Related]
10. Utility of [
Kavanaugh G; Williams J; Morris AS; Nickels ML; Walker R; Koglin N; Stephens AW; Washington MK; Geevarghese SK; Liu Q; Ayers D; Shyr Y; Manning HC
Mol Imaging Biol; 2016 Dec; 18(6):924-934. PubMed ID: 27677886
[TBL] [Abstract][Full Text] [Related]
11. Initial evaluation of (4S)-4-(3-[
Park SY; Mosci C; Kumar M; Wardak M; Koglin N; Bullich S; Mueller A; Berndt M; Stephens AW; Chin FT; Gambhir SS; Mittra ES
EJNMMI Res; 2020 Aug; 10(1):100. PubMed ID: 32857284
[TBL] [Abstract][Full Text] [Related]
12. Specific PET imaging of xC- transporter activity using a ¹⁸F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism.
Koglin N; Mueller A; Berndt M; Schmitt-Willich H; Toschi L; Stephens AW; Gekeler V; Friebe M; Dinkelborg LM
Clin Cancer Res; 2011 Sep; 17(18):6000-11. PubMed ID: 21750203
[TBL] [Abstract][Full Text] [Related]
13. Clinical [
Sharkey AR; Koglin N; Mittra ES; Han S; Cook GJR; Witney TH
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611114
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.
Chiotellis A; Mu L; Müller A; Selivanova SV; Keller C; Schibli R; Krämer SD; Ametamey SM
Eur J Med Chem; 2013; 70():768-80. PubMed ID: 24239624
[TBL] [Abstract][Full Text] [Related]
15. Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
Mittra ES; Koglin N; Mosci C; Kumar M; Hoehne A; Keu KV; Iagaru AH; Mueller A; Berndt M; Bullich S; Friebe M; Schmitt-Willich H; Gekeler V; Fels LM; Bacher-Stier C; Moon DH; Chin FT; Stephens AW; Dinkelborg LM; Gambhir SS
PLoS One; 2016; 11(2):e0148628. PubMed ID: 26890637
[TBL] [Abstract][Full Text] [Related]
16.
Wardak M; Sonni I; Fan AP; Minamimoto R; Jamali M; Hatami N; Zaharchuk G; Fischbein N; Nagpal S; Li G; Koglin N; Berndt M; Bullich S; Stephens AW; Dinkelborg LM; Abel T; Manning HC; Rosenberg J; Chin FT; Gambhir SS; Mittra ES
Radiology; 2022 Jun; 303(3):620-631. PubMed ID: 35191738
[TBL] [Abstract][Full Text] [Related]
17. (S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetry.
Smolarz K; Krause BJ; Graner FP; Wagner FM; Hultsch C; Bacher-Stier C; Sparks RB; Ramsay S; Fels LM; Dinkelborg LM; Schwaiger M
J Nucl Med; 2013 Jun; 54(6):861-6. PubMed ID: 23568366
[TBL] [Abstract][Full Text] [Related]
18. Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)?
Regier M; Derlin T; Schwarz D; Laqmani A; Henes FO; Groth M; Buhk JH; Kooijman H; Adam G
Eur J Radiol; 2012 Oct; 81(10):2913-8. PubMed ID: 22197090
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Han A; Xue J; Hu M; Zheng J; Wang X
Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
